TY - JOUR
T1 - Genome-wide Association Study of Asthma Exacerbations in the Spanish Population
AU - Martín González, Elena
AU - Pérez García, Javier
AU - Martín Almeida, Mario
AU - Hernández Pérez, José María
AU - González Pérez, Ruperto
AU - Sardón Prado, Olaia
AU - Pérez Pérez, Jose Antonio
AU - González Carracedo, Mario A.
AU - Poza Guedes, Paloma
AU - Sánchez Machín, María Inmaculada
AU - Mederos Luis, Elena
AU - Corcuera, Paula
AU - López Fernández, Leyre
AU - Román Bernal, Berta
AU - González García, Luis Manuel
AU - Cruz, María Jesús
AU - González Barcala, Francisco Javier
AU - Martínez Rivera, Carlos
AU - Mullol Miret, Joaquim
AU - Muñoz, Xavier
AU - Olaguíbel Rivera, José María
AU - Plaza Moral, Vicente
AU - Quirce Gancedo, Santiago
AU - Valero Santiago, Antonio Luis
AU - Sastre Merlín, Joaquín
AU - Pozo Abejón, Victoria del
AU - Fernández Villar, Jesús Manuel
AU - Lorenzo Díaz, Luis Fabián
AU - Pino Yanes, María del Mar del
PY - 2025/8
Y1 - 2025/8
N2 - This work was funded by grant PID2020-116274RB-I00 funded by MICIU/AEI/10.13039/501100011033 (Spanish Ministry of Science, Innovation, and Universities) and grant PIFIISC22/24 by Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). This work was alsopartially fundedby a grantfromSociedad Espanola ˜ de Alergología e Inmunología Clínica (SEAIC) to RGP, grant SAF2017-83417R by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” and grant A23100219 from the CSL Behring. EM-G was funded by a fellowship (TESIS2022010045) co-financed by the Canarian Agency for Research, Innovation and the Information Society ofthe Counseling of Universities, Science and Innovation and Culture and by the European Social Fund Plus (ESF+) Integrated Operational Program of the Canary Islands 2021–2027, Axis 3 Priority Theme 74 (85%). JP-G was funded by fellowship FPU19/02175 (Formación de Profesorado Universitario Program) from the MICIU. MM-A was funded by fellowships FPI2024010123 co-financed by the Canarian Agency for Research, Innovation and the Information Society of the Counseling of Universities, Science and Innovation and Culture and by the European Social Fund Plus (ESF+) Integrated Operational Program ofthe Canary Islands 2021-2027,Axis 3 Priority Theme 74 (85%) and FPU23/02667 (Formación de Profesorado Universitario Program) from the Spanish Ministry of Science, Innovation and Universities. JV was funded by Instituto de Salud Carlos III, Madrid, Spain (PI19/00141, AC21 2/00039), ERAPerMed (JTC 2021),the European Regional Development Funds, FundaciónCanaria Institutode Investigación Sanitaria de Canarias, Spain (PIFIISC21-36), and Asociación Científica Pulmón y Ventilación Mecánica, Spain. JV and MP-Y also received funding from CIBER – Consorcio Centro de Investigación Biomédica en Red (CIBERES), Instituto de Salud Carlos III (ISCIII), and European Regional Development Fund (CB06/06/1088).
AB - This work was funded by grant PID2020-116274RB-I00 funded by MICIU/AEI/10.13039/501100011033 (Spanish Ministry of Science, Innovation, and Universities) and grant PIFIISC22/24 by Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). This work was alsopartially fundedby a grantfromSociedad Espanola ˜ de Alergología e Inmunología Clínica (SEAIC) to RGP, grant SAF2017-83417R by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” and grant A23100219 from the CSL Behring. EM-G was funded by a fellowship (TESIS2022010045) co-financed by the Canarian Agency for Research, Innovation and the Information Society ofthe Counseling of Universities, Science and Innovation and Culture and by the European Social Fund Plus (ESF+) Integrated Operational Program of the Canary Islands 2021–2027, Axis 3 Priority Theme 74 (85%). JP-G was funded by fellowship FPU19/02175 (Formación de Profesorado Universitario Program) from the MICIU. MM-A was funded by fellowships FPI2024010123 co-financed by the Canarian Agency for Research, Innovation and the Information Society of the Counseling of Universities, Science and Innovation and Culture and by the European Social Fund Plus (ESF+) Integrated Operational Program ofthe Canary Islands 2021-2027,Axis 3 Priority Theme 74 (85%) and FPU23/02667 (Formación de Profesorado Universitario Program) from the Spanish Ministry of Science, Innovation and Universities. JV was funded by Instituto de Salud Carlos III, Madrid, Spain (PI19/00141, AC21 2/00039), ERAPerMed (JTC 2021),the European Regional Development Funds, FundaciónCanaria Institutode Investigación Sanitaria de Canarias, Spain (PIFIISC21-36), and Asociación Científica Pulmón y Ventilación Mecánica, Spain. JV and MP-Y also received funding from CIBER – Consorcio Centro de Investigación Biomédica en Red (CIBERES), Instituto de Salud Carlos III (ISCIII), and European Regional Development Fund (CB06/06/1088).
UR - https://dialnet.unirioja.es/servlet/articulo?codigo=10347360
UR - https://www.scopus.com/pages/publications/105001813128
UR - https://www.mendeley.com/catalogue/b573abc2-5594-3bde-b643-542f935b1835/
U2 - 10.1016/j.arbres.2025.03.012
DO - 10.1016/j.arbres.2025.03.012
M3 - Article
C2 - 40187921
SN - 0300-2896
VL - 61
SP - 490
EP - 494
JO - Archivos de Bronconeumologia
JF - Archivos de Bronconeumologia
IS - 8
ER -